Cellular Bioengineering Revenue and Competitors
Estimated Revenue & Valuation
- Cellular Bioengineering's estimated annual revenue is currently $775k per year.
- Cellular Bioengineering's estimated revenue per employee is $155,000
Employee Data
- Cellular Bioengineering has 5 Employees.
- Cellular Bioengineering grew their employee count by -17% last year.
Cellular Bioengineering's People
Name | Title | Email/Phone |
---|
Cellular Bioengineering Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $10.1M | 65 | 5% | N/A | N/A |
#10 | $16.1M | 104 | 9% | N/A | N/A |
What Is Cellular Bioengineering?
Cellular Bioengineering Inc. (CBI) is a Hawaii based accelerator of disruptive technologies with biomedical and biodefense applications. CBI searches for innovative and ingenious ideas which it can nurture and grow into mature products that will change the way the world operates. It has brought forward suites of technology at varying stages of development which have favorably impacted health care and homeland security in our country. CBI is a developer of intellectual property. It will invent, license, or acquire IP which it can then incubate and accelerate to a functional end use which can make the world healthier, safer, and a better place for all of mankind. Each of its operating divisions has a flagship technology which has contributed to wellness and security in our country and worldwide.
keywords:N/AN/A
Total Funding
5
Number of Employees
$775k
Revenue (est)
-17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.5M | 5 | -17% | $76.7M |
#2 | $0.7M | 5 | N/A | N/A |
#3 | $0.3M | 5 | N/A | N/A |
#4 | $0.5M | 5 | N/A | N/A |
#5 | $0.5M | 5 | N/A | N/A |